← back to search

Stefano Cattaneo

University of Ferrara · IT
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Biology, Genetic enhancement, Neuroscience, Epilepsy, Neuropeptide Y receptor, and Parkin.
h-index
citations
203
works
13
NIH funding
primary concept
email

Recent publications

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
Gene Therapy 2026cited by 0position: firstdoi
Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
Frontiers in Physiology 2025cited by 5position: middledoi
AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus
Molecular Therapy 2025cited by 2position: middledoi
Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications
Gene Therapy 2025cited by 1position: firstdoi
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
EMBO Reports 2024cited by 10position: firstdoi
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays
European Journal of Pharmacology 2024cited by 1position: middledoi
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
Molecular Diagnosis & Therapy 2023cited by 12position: middledoi
NPY and Gene Therapy for Epilepsy: How, When,... and Y
Frontiers in Molecular Neuroscience 2021cited by 60position: firstdoi
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells
Molecular Therapy — Methods & Clinical Development 2021cited by 15position: middledoi
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity
Cell Death and Disease 2020cited by 25position: middledoi
Pharmacological Antagonism of Kainate Receptor Rescues Dysfunction and Loss of Dopamine Neurons in a Mouse Model of Human Parkin-induced Toxicity
2020cited by 6position: middledoi
Parkinson’s disease recovery by GM1 oligosaccharide treatment in the B4galnt1+/− mouse model
Scientific Reports 2019cited by 50position: middledoi
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy
Epiliepsy currents/Epilepsy currents 2019cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michele Simonato · University of Ferrara9 papers (2019–2026) · 9 papers (2021–2026)Silvia Zucchini · University of Ferrara6 papers (2019–2026)Gianluca Verlengia · University of Ferrara5 papers (2019–2026)Selene Ingusci · University of Ferrara4 papers (2019–2026)Marie Soukupovà · University of Edinburgh3 papers (2021–2024) · 3 papers (2020–2024) · 3 papers (2020–2024) · 3 papers (2024–2026) · 2 papers (2025–2026)Jenny Sassone · University of Ferrara2 papers (2020–2020)Laura Croci · Vita-Salute San Raffaele University2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020)Michele Morari · University of Ferrara2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2020–2020) · 2 papers (2024–2025)G. Giacomo Consalez · Vita-Salute San Raffaele University2 papers (2020–2020)